Progressive Supranuclear Palsy Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

 

(Albany, US) DelveInsight has launched a new report on Progressive Supranuclear Palsy Market Insights, Epidemiology, and Market Forecast-2030.

DelveInsight’s ‘ Progressive Supranuclear Palsy Market Insights, Epidemiology, and Market Forecast-2030’ report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Progressive Supranuclear Palsy in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Some of Progressive Supranuclear Palsy facts:

·         According to Delveinsight, prevalence of PSP was 1.89 per 100,000 and age-standardized prevalence to the US population was 2.95 per 100,000.

·         DelveInsight’s Analysts, estimated that the prevalence of PSP in the UK was 1.0 per 100,000. The age-adjusted standardized prevalence figure for PSP from this study was observed to be 5.0.

·         According to a study conducted by Kawashima et al. 2004, in Japan the prevalence of PSP was 5.82 per 100,000

·         United States has the highest percentage of prevalent diagnosed and treated patients

Request for free Sample Report: https://www.delveinsight.com/sample-request/progressive-supranuclear-palsy-market

View Report: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market

Scope of Progressive Supranuclear Palsy Report:

  • The report covers the descriptive overview of Progressive Supranuclear Palsy , explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
  • Comprehensive insight has been provided into the Progressive Supranuclear Palsy epidemiology and treatment in the 7MM
  • Additionally, an all-inclusive account of both the current and emerging therapies for Progressive Supranuclear Palsy are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
  • A detailed review of Progressive Supranuclear Palsy market; historical and forecasted is included in the report, covering drug outreach in the 7MM
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Progressive Supranuclear Palsy market

Request for free Sample Report: https://www.delveinsight.com/sample-request/progressive-supranuclear-palsy-market

View Report: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market

Progressive Supranuclear Palsy (PSP) is a rare progressive condition that can cause problems with balance, movement, vision, speech and swallowing.

The condition has been linked to changes in certain genes, but these genetic faults are not inherited and the risk to other family members (including the children or siblings) with PSP, is very low. Although PSP is not fatal, symptoms do continue to worsen and it can not be cured.

Complications that result from worsening symptoms, such as pneumonia (from breathing in food particles while choking during eating) can be life threatening. There are different subtypes of PSP which incudes, PSP with Richardson’s syndrome (PSP-RS), PSP with predominant parkinsonism (PSP-P), PSP with pure akinesia with gait freezing (PSP- PAGF), PSP with corticobasal syndrome (PSP-CBS), PSP with predominant language and speech dysfunction (PSP-PNFA and PSP-AOS), PSP with predominant frontotemporal dysfunction (PSP-FTD), PSP with cerebellar ataxia (PSP-C), and PSP with primary lateral sclerosis (PSP-PLS).

The only proven risk factor for PSP is age. The condition typically affects people around the age of 60, and is virtually unknown in people under the age of 40.

There's no single test for PSP. Instead, the diagnosis is based on the pattern of the symptoms.

The large number of possible symptoms of PSP also makes it difficult to diagnose correctly and can mean it takes a while to get a definitive diagnosis. Apart from this, PSP is often misdiagnosed as Parkinson disease, Alzheimer disease, corticobasal degeneration and other neurodegenerative disorders.

Request for free Sample Report: https://www.delveinsight.com/sample-request/progressive-supranuclear-palsy-market

View Report: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market

Some of Progressive Supranuclear Palsy Companies:

·         AlzProtect

·         UCB Biopharma

·         Asceneuron Therapeutics

·         TauRx Pharmaceuticals

·         And Many Others

Progressive Supranuclear Palsy Drugs Covered:

·         AZP2006

·         UCB0107

·         ASN120290

·         LMTX

·         And Many Others

Request for free Sample Report: https://www.delveinsight.com/sample-request/progressive-supranuclear-palsy-market

View Report: https://www.delveinsight.com/report-store/progressive-supranuclear-palsy-market

Table of Contents:

1 Key Insights

2 Executive Summary of Progressive Supranuclear Palsy

3 SWOT Analysis for Progressive Supranuclear Palsy

5 Disease Background and Overview

6 Epidemiology and Patient Population

7 Country Wise-Epidemiology of Progressive Supranuclear Palsy (PSP)

8 Treatment

9 Unmet Needs

10 Emerging drugs

11 Other promising candidates

12 No development reported

13 Discontinued therapies

14 Progressive Supranuclear Palsy (PSP): Seven Major Market Analysis

15 United States

16 EU5 Countries

17 Japan

18 Market Drivers

19 Market Barriers

20 Appendix

21 DelveInsight Capabilities

22 Disclaimer

23 About DelveInsight

Related Reports:

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

 

 

Comments

Post a Comment

Popular posts from this blog

How Competitive intelligence is transforming the scenario for Biotech firms?

What is Competitive intelligence service? Competitive intelligence ideally means gathering information on rival business in the market, analyse the information and use the information to strategize to yield positive results. Going by the definition, competitive intelligence assembles actionable information from diverse published and unpublished sources, collected efficiently and ethically. So, analysts performing Competitive intelligence for their clienteles present a detailed picture of the marketplace, forthcoming challenges and the ways to face them, even before the can harm the client’s business. What could it mean? Competitive intelligence can often give a wrong idea, as it may misunderstood as a service which can help gain an advantage over the rivals. However, this is not the case. Competitive intelligence is an ethical and legal practise undertaken involving the study of analytical data, analysing the market and optimizing the relevant and realistic strategies t...
Read more

Cervical Intraepithelial Neoplasia Market and Epidemiology 2032 by DelveInsight

DelveInsight's " Cervical Intraepithelial Neoplasia Market Insights, Epidemiology, and Market Forecast-2032 " report delivers an in-depth understanding of Cervical Intraepithelial Neoplasia, historical and forecasted epidemiology as well as the Cervical Intraepithelial Neoplasia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Cervical Intraepithelial Neoplasia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Cervical Intraepithelial Neoplasia market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Cervical Intraepithelial Neoplasia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Cervical Intraepithelial Neoplasia market. Request for a Free Sample Report: Cervic...
Read more

The Need And The Importance Of The Healthcare Reports for the Pharma Companies

Image
It is very important for the hospitals and the other medical institutions to preserve and keep the healthcare reports of all the patients very safe and secure. All the medical records are being kept by almost all of these institutes. As a matter of fact, the healthcare reports are very important for comprehending the medical history of the patient. If he or she suffers from the same ailment once more the previous reports will be absolutely indispensible while treating him or her. Nowadays, with the advancement of technology the manual records are slowly and gradually getting digitalized. It is easier to store and preserve the digital records than the manual and the physical ones.  Choosing The Best And The Most Professional Services For Healthcare Reports: • Rising Pharma Market for You Now In the market there are a host of companies that preserves the healthcare reports of the various patients. All of it is now being done in the digital format due to the adv...
Read more